Stereotaxis Interest Expense 2011-2026 | STXS

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Stereotaxis

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
2 K	694 K	30 K	484 K	-11 K	67.4 K	236 K	16.6 K	180 K	2.48 M	3.28 M	3.34 M	12.6 M	6.89 M	3.52 M	3.04 M	4.61 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
12.6 M	-11 K	2.44 M

Quarterly Interest Expense Stereotaxis

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-5 K	3 K	-1 K	106 K	5 K	-3 K	239 K	270 K	27 K	272 K	-	135 K	45 K	3 K	-	1 K	-3 K	-4 K	-	-9.93 K	567	81 K	-	85 K	-31.8 K	-16.6 K	-	2.52 K	6.14 K	24.6 K	-	43.1 K	42.8 K	49.5 K	-	819 K	829 K	819 K	-	815 K	816 K	830 K	-	834 K	835 K	837 K	-	7.64 M	2.15 M	1.93 M	-	1.58 M	1.83 M	1.45 M	-	830 K	773 K	810 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
7.64 M	-31.8 K	604 K

Interest Expense of other stocks in the Medical instruments industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
The Cooper Companies COO	-16.4 M	$ 59.78	-0.99 %	$ 11.9 B	USA
Atrion Corporation ATRI	149	-	-	$ 810 M	USA
iRhythm Technologies IRTC	5.44 M	$ 114.31	0.13 %	$ 3.66 B	USA
ICU Medical ICUI	93.3 M	$ 119.39	-2.93 %	$ 2.94 B	USA
Repro Med Systems KRMD	9.91 K	$ 3.93	-1.26 %	$ 182 M	USA
Alcon ALC	204 M	$ 63.78	-0.34 %	$ 40.4 B	Schweiz
LeMaitre Vascular LMAT	5.18 M	$ 97.38	-2.13 %	$ 2.2 B	USA
Masimo Corporation MASI	300 K	$ 178.49	0.08 %	$ 9.51 B	USA
Ekso Bionics Holdings EKSO	-26 K	-	-	$ 28.6 M	USA
Envista Holdings Corporation NVST	-2.3 M	$ 23.4	-1.89 %	$ 3.93 B	USA
electroCore ECOR	14.9 K	$ 6.04	-6.07 %	$ 51.2 K	USA
Haemonetics Corporation HAE	-9.75 M	$ 56.73	-0.68 %	$ 2.86 B	USA
Isoray ISR	84 K	-	0.03 %	$ 108 M	USA
Glaukos Corporation GKOS	13.6 M	$ 143.49	0.93 %	$ 6.95 B	USA
STAAR Surgical Company STAA	2.25 M	$ 32.41	1.25 %	$ 1.61 B	USA
STERIS plc STE	8.4 M	$ 211.83	-1.92 %	$ 20.9 B	USA
Teleflex Incorporated TFX	85.1 M	$ 130.52	0.18 %	$ 5.82 B	USA
InfuSystem Holdings INFU	2 K	$ 8.65	0.46 %	$ 179 M	USA
Microbot Medical MBOT	-5 K	$ 1.88	1.35 %	$ 86.1 M	Israel
Milestone Scientific MLSS	60.3 K	$ 0.33	-2.77 %	$ 27.1 M	USA
Merit Medical Systems MMSI	-2.39 M	$ 61.59	-1.55 %	$ 3.64 B	USA
Utah Medical Products UTMD	-120 K	$ 63.27	-0.68 %	$ 205 M	USA
West Pharmaceutical Services WST	-1 M	$ 303.95	1.25 %	$ 22 B	USA
Pulse Biosciences PLSE	-52 K	$ 24.33	-10.22 %	$ 1.64 B	USA
DENTSPLY SIRONA XRAY	24 M	$ 9.99	-3.99 %	$ 1.99 B	USA
Retractable Technologies RVP	227 K	$ 0.65	-5.8 %	$ 19.5 M	USA
Pro-Dex PDEX	533 K	$ 59.75	1.88 %	$ 196 M	USA
Predictive Oncology POAI	3	-	-	$ 31.1 M	USA
BioLife Solutions BLFS	1.82 M	$ 20.35	-3.4 %	$ 972 M	USA
Baxter International BAX	290 M	$ 17.34	-2.47 %	$ 8.9 B	USA
ResMed RMD	3.2 M	$ 202.44	-0.01 %	$ 29.6 B	USA
AtriCure ATRC	683 K	$ 28.16	0.04 %	$ 1.34 B	USA
Harvard Bioscience HBIO	-2.66 M	$ 5.37	-2.72 %	$ 238 M	USA
AngioDynamics ANGO	4.94 M	$ 10.79	-2.18 %	$ 441 M	USA
Becton, Dickinson and Company BDX	613 M	$ 143.35	-0.77 %	$ 41.2 B	USA
Nephros NEPH	-78 K	$ 3.23	-1.1 %	$ 34.3 M	USA
OraSure Technologies OSUR	229 K	$ 3.07	3.9 %	$ 226 M	USA
Repligen Corporation RGEN	2.82 M	$ 103.63	0.24 %	$ 5.83 M	USA